Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-7-16
pubmed:abstractText
Ovid and many physicians in the thousands of years since have been stymied by the large interindividual variability in drug response and toxicity. That all patients do not reap the same benefits from the same drugs is well established. In the case of statins, estimates of effectiveness range from 30 to 70% of users (Spear et al., 2001). Disentangling why this occurs is complex, and two new disciplines are likely to make headway in furthering our understanding of these phenomena.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1523-1747
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
127
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1851-2
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
The power and limitations of pharmacogenetic epidemiology.
pubmed:affiliation
Brown Medical School-Community Health, Providence, Rhode Island 02912, USA. Kate_Lapane@brown.edu
pubmed:publicationType
Journal Article, Comment